Drugs in the Pipeline
The submission was based on data from the double-blind, placebo-controlled VOYAGE trial.
News
The FDA has approved Zeposia® (ozanimod) for moderately to severely active ulcerative colitis in adults.
AAO-HNS 2021
In their presentation, Ahmad R. Sedaghat, MD, PhD and Stacey T. Gray, MD, FACS discuss both patient and physician perspectives for successful control of CRS.